News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to ...
In May, prominent members of the Make America Great Again movement, including Nicole Shanahan, Kennedy's former presidential running mate, and media personality Laura Loomer, spoke out against Kennedy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback